GlassScriptPhysician profile
Koji Ota
NPI 1972091866
$1,965.90
in general payments reported to CMS, 2019-2025
17 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $470 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,857 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.99 |
| Education | $108.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $326.36 | 2024-2025 | Zoryve |
| Abbvie INC. | $311.84 | 2024-2025 | |
| Amgen INC. | $207.86 | 2024-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $171.87 | 2025 | Dupixent, Libtayo |
| Genzyme Corporation | $163.35 | 2024-2025 | |
| Aerin Medical INC. | $143.84 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.43 | 2025 | Spevigo |
| Phathom Pharmaceuticals, INC. | $115.08 | 2024 | Voquezna |
| Lilly USA, LLC | $81.36 | 2024-2025 | Ebglyss, Taltz |
| Incyte Corporation | $75.11 | 2024-2025 | Opzelura |
| Biofrontera INC. | $67.19 | 2025 | |
| Galderma Laboratories, L.P. | $42.58 | 2025 | Aklief, Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.96 | 2025 | Cabtreo, Jublia, Siliq |
| Botanix Sb INC | $26.20 | 2025 | Sofdra |
| Organon LLC | $25.32 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.55 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2025 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koji Ota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.